Autres langues Jiuzhitang Co., Ltd.

Actions

000989

CNE000001394

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 16/05/2024			Varia. 5j.	Varia. 1 janv.
7,89 ^CNY	-2,59 %		-2,35 %	-22,04 %

24/04	Jiuzhitang Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
18/03	Jiuzhitang Co, Ltd (SZSE:000989) annonce un rachat d'actions pour une valeur de 100 millions CNY. (SZSE:000989) annonce un rachat d'actions pour une valeur de 100 millions CNY.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Jiuzhitang Co., Ltd.(XSEC:000989) dropped from S&P Global BMI Index	08/05
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	25/04
Jiuzhitang Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04
Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	02/04
Jiuzhitang Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	18/03
Jiuzhitang Co., Ltd. authorizes a Buyback Plan.	18/03
Jiuzhitang's Unit to Launch Clinical Trials Into Human Bone Marrow Stem Cell Injection; Shares Drop 3%	02/11
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	08/08/23
Jiuzhitang Unit to Hold Clinical Trial Into Stem Cell Treatment	12/06/23
Jiuzhitang Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023	30/05/23
Jiuzhitang Co., Ltd. Approves Cash Dividend for the Year 2022	25/05/23
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend for 2022	04/05/23
Jiuzhitang Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Jiuzhitang Co., Ltd. Appoints Bo Jinfeng as Non-Independent Director	11/01/23
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Jiuzhitang Cleared to Launch Clinical Trial of Deep Vein Thrombosis Drug	22/09/22
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22
Jiuzhitang Co., Ltd. Appoints Wang Yonghui as a Non-Independent Director	17/08/22
Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021 Payable on 01 June 2022	26/05/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Jiuzhitang Co., Ltd.

Actions

000989

CNE000001394

Autres langues

Filtres